What is Duvelisib?

Duvelisib (Duvelisib) is a targeted therapy drug that belongs to the PI3K inhibitor category. PI3K stands for phosphatidylinositide 3kinase (Phosphoinositide 3-kinase), an enzyme involved in a variety of biological processes within cells, including cell growth, differentiation, and survival. The main function of duveliced u200bu200bis to inhibit the PI3K signaling pathway, thereby interfering with the growth and spread of cancer cells.

Duveliside is commonly used to treat certain types of lymphoma, including:

1.AdultTCell Leukemia Lymphoma/Lymphoma Cell Leukemia (ATLL/CTCL): This is a rare type of leukemia usually associated with T cells. Duveliced u200bu200bcan be used to treat patients with ATLL/CTCL, especially those who are refractory to other treatments or who have relapsed.

2.Relapsed smallB cell lymphoma: This is a type of lymphoma involving B cells. Duveliside can also be used to treat patients who relapse after first-line treatment.

The mechanism of action of duvelicet involves inhibiting multiple subtypes of the PI3K signaling pathway, including the delta type and the γ type. This multi-target mechanism of action helps interfere with different biological processes of cancer cells, thereby slowing their growth and spread.

Patients usually need a doctor's prescription to obtain duvelised, and use it under a doctor's supervision. During treatment, patients need to receive regular medical monitoring to ensure the safety and efficacy of the drug. Duvelisel may cause some side effects, including infection, pain, diarrhea, nausea, vomiting, fatigue, etc., so patients need to pay close attention and share any discomfort or unusual symptoms with their doctor.

In summary, duveliside is an oral drug used to treat certain types of lymphoma, interfering with the growth of cancer cells by inhibiting thePI3Ksignaling pathway. Patients should use it under the guidance of a doctor and undergo regular medical monitoring to ensure the safety and effectiveness of treatment.

The original drug of Duvelisel Capsules has been launched in China, but it is not covered by medical insurance. Patients can buy it domestically at a price of more than 20,000 yuan. For specific prices, please consult the local hospital pharmacy.